TURNSTONE BIOLOGICS CORP (TSBX) Stock Analyst Earnings Estimates
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 101.293M | 73.3M -27.64% | 19.306M -73.66% | -100.00% | 14.28M | 53.397M 273.93% | 143.36M 168.48% | 294.47M 105.41% | |||||
| EBITDA YoY % growth | 34.383M | -27.725M -180.64% | -56.234M -102.83% | -81.569M -45.05% | -60.782M 25.48% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 32.993M | -31.626M -195.86% | -59.032M -86.66% | -80.69M -36.69% | -16.371M 79.71% | -8.16M 50.16% | -139.536M -1,610.00% | -178.459M -27.89% | -223.38M -25.17% | -169.32M 24.20% | -139.74M 17.47% | 131.58M 194.16% | |
| Operating Margin | 32.57% | -43.15% | -305.77% | N/A | N/A | N/A | N/A | N/A | -1,564.29% | -317.10% | -97.47% | 44.68% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.35 44.38% | -0.69 79.45% | -0.34 51.11% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.78 -6.89% | -0.40 52.60% | -0.17 81.15% | -0.07 90.35% | -0.83 -5.88% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -22.246M -47.74% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.36M -2.82% | -9.486M 54.15% | -4.182M 81.04% | -1.683M 90.84% | -21.93M -19.44% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.74 26.00% | -0.88 | 0.14 | 15.64% |
| Q2 2024 Q2Q % growth | -0.92 87.83% | -0.95 | 0.03 | 3.01% |
| Q1 2024 Q2Q % growth | -0.85 | -0.79 | -0.06 | -7.53% |
| Q4 2023 Q2Q % growth | -0.73 | -0.88 | 0.15 | 17.10% |
| Q3 2023 Q2Q % growth | -1.00 | -0.68 | -0.32 | -47.43% |
| Q2 2023 Q2Q % growth | -7.56 | -3.07 | -4.49 | -146.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | 19.306M 80.13% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 10% | 8.57% | 3.57% | 6.41% |
| Revenue | N/A | N/A | N/A | N/A |